We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $135M
1-Year Est. Return 0.15%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+0.15%
3 Year Est. Return
-0.04%
5 Year Est. Return
-7.65%
10 Year Est. Return
–
AUM
$39.4M
AUM Growth
-$54.1M
Cap. Flow
-$41.6M
Cap. Flow %
-105.57%
Top 10 Hldgs %
95.65%
Holding
123
New
16
Increased
1
Reduced
3
Closed
94

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$714K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$462K
3
BHC icon
Bausch Health
BHC
+$222K
4
THC icon
Tenet Healthcare
THC
+$194K
5
BLUE
bluebird bio
BLUE
+$174K

Top Sells

Rank Stock Value
1
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$1.71M
2
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$1.19M
3
OFIX icon
Orthofix Medical
OFIX
+$996K
4
ESRX
Express Scripts Holding Company
ESRX
+$648K
5
EW icon
Edwards Lifesciences
EW
+$640K

Sector Composition

Rank Sector Weight
1 Healthcare 17.09%
2 Consumer Discretionary 0.45%
3 Communication Services 0%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGND
101
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
– –
-5,000
Closed -$148K
IMPR
102
DELISTED
IMPRIVATA, INC COM
IMPR
– –
-22,000
Closed -$391K
POWR
103
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
– –
-25,000
Closed -$288K
SUNE
104
DELISTED
SUNEDISON, INC COM
SUNE
– –
-20,000
Closed -$144K
ATML
105
DELISTED
ATMEL CORP
ATML
– –
-50,000
Closed -$404K
PMCS
106
DELISTED
P M C SIERRA INC
PMCS
– –
-50,000
Closed -$339K
AWAY
107
DELISTED
HOMEAWAY INC COM
AWAY
– –
-7,500
Closed -$199K
C.WS.B
108
DELISTED
CITIGROUP INC WTS EXP (10/28/2018) (DE)
C.WS.B
– –
-82,160
Closed -$1K
CYBX
109
DELISTED
CYBERONICS INC
CYBX
– –
-7,500
Closed -$456K
BEAT
110
DELISTED
BioTelemetry, Inc.
BEAT
– –
-35,000
Closed -$428K
EMKR
111
DELISTED
Emcore Corp
EMKR
– –
-1,500
Closed -$102K
OSIR
112
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
– –
-22,000
Closed -$406K
AFAM
113
DELISTED
Almost Family Inc
AFAM
– –
-8,000
Closed -$320K
RBS.PRL.CL
114
DELISTED
Royal Bank Of Scotland Group Plc
RBS.PRL.CL
– –
-12,487
Closed -$303K
HTCH
115
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
– –
-25,000
Closed -$40K
1 2 3 4
5

Similar funds

UOP
University of Pittsburgh Pittsburgh, Pennsylvania $135M AUM 29.36% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
ICM
Isabella Capital Management London $135M AUM
EC
Enhancing Capital Harrisburg, Pennsylvania $135M AUM 25.85% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
JAA
Joel Adams & Associates Asheville, North Carolina $135M AUM 10.83% 1-Year Est. Return

Piper Sandler & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Piper Sandler & Co held 123 positions worth $39.4M, down 58% from $93.5M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Piper Sandler & Co withdrew a net $41.6M in Q4 2015, closing 94 positions and reducing 3 holdings. Its most notable exit was ProShares UltraPro Short S&P 500, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Piper Sandler & Co opened a new position in Teva Pharmaceuticals worth $759K.

  • Piper Sandler & Co's largest Q4 2015 buy was Teva Pharmaceuticals: 11,559 shares worth $759K.
  • Piper Sandler & Co's biggest Q4 2015 reduction was vTv Therapeutics, cutting an estimated $626K.
  • Piper Sandler & Co fully exited ProShares UltraPro Short S&P 500 in Q4 2015, selling an estimated $1.71M.
  • Piper Sandler & Co's ten largest holdings make up 96% of its $39.4M portfolio in Q4 2015.
  • Piper Sandler & Co opened 16 new positions and closed 94 in Q4 2015.
  • Piper Sandler & Co's portfolio value fell 58% quarter-over-quarter to $39.4M.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.